Vincent Nadeem

发表

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

B. Faubert, Russell G. Jones, S. Berger, 2011, Genes & development.

MIP-1alpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma.

P. L. Bergsagel, S. Trudel, A. Stewart, 2006, Blood.

Selection of recombinant anti‐SH3 domain antibodies by high‐throughput phage display

T. Pawson, J. Moffat, S. Sidhu, 2015, Protein science : a publication of the Protein Society.

Optimizing Production of Antigens and Fabs in the Context of Generating Recombinant Antibodies to Human Proteins

J. Greenblatt, A. Koide, S. Koide, 2015, PloS one.

The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents.

Narendra Kumar Patel, Y. Liu, T. Mak, 2015, Journal of medicinal chemistry.

A molecular compendium of genes expressed in multiple myeloma.

J. Woodgett, A. Stewart, C. Liew, 2002, Blood.

Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.

Narendra Kumar Patel, T. Mak, N. Chirgadze, 2014, Bioorganic & medicinal chemistry.

Selection of recombinant anti‐SH3 domain antibodies by high‐throughput phage display

T. Pawson, J. Moffat, S. Sidhu, 2015, Protein science : a publication of the Protein Society.

The discovery of Polo-like kinase 4 inhibitors: identification of (1R,2S).2-(3-((E).4-(((cis).2,6-dimethylmorpholino)methyl)styryl). 1H.indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one (CFI-400945) as a potent, orally active antitumor agent.

Narendra Kumar Patel, Y. Liu, T. Mak, 2015, Journal of medicinal chemistry.